abstract |
The invention relates to substituted xanthines of general formula (I) wherein R<1> - R<4> are defined as cited in claim 1, the tautomers, stereoisomers, mixtures, prodrugs and salts thereof which exhibit valuable pharmacological properties, particularly an inhibitory effect on the activity of the dipeptidylpeptidase-IV enzyme. |